GETI B Stock Overview
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
My Notes
Capture your thoughts, links and company narrative
Getinge AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 219.80 |
| 52 Week High | SEK 240.20 |
| 52 Week Low | SEK 164.35 |
| Beta | 0.52 |
| 1 Month Change | 10.67% |
| 3 Month Change | 30.83% |
| 1 Year Change | 5.02% |
| 3 Year Change | -39.48% |
| 5 Year Change | 37.29% |
| Change since IPO | 528.00% |
Recent News & Updates
Recent updates
Getinge's (STO:GETI B) Soft Earnings Don't Show The Whole Picture
Feb 05
Does Getinge (STO:GETI B) Have A Healthy Balance Sheet?
Jan 03Getinge AB (publ)'s (STO:GETI B) Price In Tune With Earnings
Dec 05Getinge (STO:GETI B) Is Experiencing Growth In Returns On Capital
Oct 17Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly
Sep 19Pinning Down Getinge AB (publ)'s (STO:GETI B) P/E Is Difficult Right Now
Aug 23An Intrinsic Calculation For Getinge AB (publ) (STO:GETI B) Suggests It's 49% Undervalued
Aug 08Getinge AB (publ) Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 21We Like These Underlying Return On Capital Trends At Getinge (STO:GETI B)
Jun 27Getinge (STO:GETI B) Seems To Use Debt Quite Sensibly
May 11Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
Apr 25Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?
Apr 15The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 30Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's
Mar 29The Return Trends At Getinge (STO:GETI B) Look Promising
Mar 21Shareholder Returns
| GETI B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 3.5% | -1.0% | -0.5% |
| 1Y | 5.0% | 0.1% | 12.8% |
Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned 0.1% over the past year.
Return vs Market: GETI B underperformed the Swedish Market which returned 12.8% over the past year.
Price Volatility
| GETI B volatility | |
|---|---|
| GETI B Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 12.1% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: GETI B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: GETI B's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1904 | 11,791 | Mattias Perjos | www.getinge.com |
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Getinge AB (publ) Fundamentals Summary
| GETI B fundamental statistics | |
|---|---|
| Market cap | SEK 58.89b |
| Earnings (TTM) | SEK 1.64b |
| Revenue (TTM) | SEK 34.76b |
36.5x
P/E Ratio1.7x
P/S RatioIs GETI B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GETI B income statement (TTM) | |
|---|---|
| Revenue | SEK 34.76b |
| Cost of Revenue | SEK 18.61b |
| Gross Profit | SEK 16.15b |
| Other Expenses | SEK 14.52b |
| Earnings | SEK 1.64b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 22, 2025
| Earnings per share (EPS) | 6.01 |
| Gross Margin | 46.47% |
| Net Profit Margin | 4.71% |
| Debt/Equity Ratio | 26.9% |
How did GETI B perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield76%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 18:44 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Getinge AB (publ) is covered by 31 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Kamla Singh | AlphaValue |
| Scott Bardo | Berenberg |